Epidermis: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Epidermis
Largest movements
- Cash +€61,685
up €61,685 (+301%), from €20,499 to €82,184
mainly Net result for the year (+€52,957) and Tax, wage and social debts (+€8,142)
- Receivables within one year -€3,014
down €3,014 (-16.0%), from €18,787 to €15,774
of which Trade receivables: -€1,896
- Tangible fixed assets +€1,037
up €1,037 (+63.3%), from €1,639 to €2,676
- Reserves +€52,957
up €52,957 (+162%), from €32,704 to €85,661
- Tax, wage and social debts +€8,142
up €8,142 (+17,315%), from €47 to €8,189
of which Taxes: +€7,927
- Other debts -€2,993
down €2,993 (-60.1%), from €4,983 to €1,990
- Trade debts +€1,441
up €1,441 (+407%), from €354 to €1,794
- Gross operating margin +€26,758
up €26,758 (+64.8%), from €41,320 to €68,078
- Taxes +€4,556
up €4,556 (+50.7%), from €8,987 to €13,543
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €41,088 | €100,633 | +€59,546 | +145% |
| Fixed assets | 21/28 | €1,639 | €2,676 | +€1,037 | +63.3% |
| Tangible fixed assets | 22/27 | €1,639 | €2,676 | +€1,037 | +63.3% |
| Plant, machinery and equipment | 23 | €1,639 | €2,676 | +€1,037 | +63.3% |
| Current assets | 29/58 | €39,449 | €97,957 | +€58,509 | +148% |
| Amounts receivable within one year | 40/41 | €18,787 | €15,774 | -€3,014 | -16.0% |
| Trade receivables | 40 | €17,670 | €15,774 | -€1,896 | -10.7% |
| Other amounts receivable | 41 | €1,117 | - | -€1,117 | |
| Cash at bank and in hand | 54/58 | €20,499 | €82,184 | +€61,685 | +301% |
| Deferred charges and accrued income | 490/1 | €163 | - | -€163 | |
| Total equity and liabilities | 10/49 | €41,088 | €100,633 | +€59,546 | +145% |
| Equity | 10/15 | €35,704 | €88,661 | +€52,957 | +148% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €32,704 | €85,661 | +€52,957 | +162% |
| Distributable reserves | 133 | €32,704 | €85,661 | +€52,957 | +162% |
| Amounts payable | 17/49 | €5,384 | €11,973 | +€6,589 | +122% |
| Amounts payable within one year | 42/48 | €5,384 | €11,973 | +€6,589 | +122% |
| Trade debts | 44 | €354 | €1,794 | +€1,441 | +407% |
| Suppliers | 440/4 | €354 | €1,794 | +€1,441 | +407% |
| Taxes, remuneration and social security | 45 | €47 | €8,189 | +€8,142 | +17,315% |
| Taxes | 450/3 | €47 | €7,974 | +€7,927 | +16,858% |
| Remuneration and social security | 454/9 | - | €215 | +€215 | |
| Other amounts payable | 47/48 | €4,983 | €1,990 | -€2,993 | -60.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €39 | €641 | +€601 | +1,525% |
| Other operating charges | 640/8 | - | €427 | +€427 | |
| Gross operating margin | 9900 | €41,320 | €68,078 | +€26,758 | +64.8% |
| Operating profit (loss) | 9901 | €41,280 | €67,010 | +€25,730 | +62.3% |
| Financial charges | 65/66B | €113 | €510 | +€397 | +351% |
| Recurring financial charges | 65 | €113 | €510 | +€397 | +351% |
| Profit (loss) for the period before taxes | 9903 | €41,167 | €66,500 | +€25,333 | +61.5% |
| Income taxes | 67/77 | €8,987 | €13,543 | +€4,556 | +50.7% |
| Profit (loss) for the period | 9904 | €32,180 | €52,957 | +€20,777 | +64.6% |
| Profit (loss) for the period to be appropriated | 9905 | €32,180 | €52,957 | +€20,777 | +64.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.